|
Home >Advocacy > AIM for the B Campaign
AIM for the B Campaign Spotlights Hepatitis B
May 7-11, 2007
“AIM for the B” (Awareness, Involvement and Mobilization for Chronic Hepatitis B) is a public awareness programto engage the media in promoting hepatitis B as an urgent health priority. Activities are scheduled to complement National Hepatitis B Awareness Week (May 7-11, 2007).
AIM for the B is designed to illustrate the significant impact associated with chronic hepatitis B through testimonies from patients, physicians and third-party organizations that are involved first-hand with the disease. The Hepatitis B Foundation serves as host and moderator of the media roundtables, which are held across the country.
The campaign puts hepatitis B in the national spotlight because Americans lack awareness about the seriousness of this disease. Chronic hepatitis B is potentially a life-threatening disease, and yet patients often feel their diagnosis is not serious since they typically do not experience symptoms and that a “watch and wait” approach is often taken in managing their disease.
As part of the program, a series of local events will be held in
four cities where chronic hepatitis B prevalence is high.
- May 5 (10:00-11:30 am): Marriott Waikiki Beach Resort, Honolulu, HI
Dr. Naoky Tsai, Dr. David, Mai, Dr. Ida Mai, and Dr. Fernando Ona
- May 7 (9:00–10:30 am): Hotel Nikko San Francisco, San Francisco, CA
Molli Conti (HBF), Dr. Eddie Cheung (U.C. Davis), Dr. Huy Trinh, (Gastroenterologist, San Jose)
- May 9 (9:00–10:30 am): USC University Hospital,
Los Angeles, CA
Molli Conti (HBF), Dr. Tse-Ling Fong (U. Southern Calif.), Dr. Tram Tran (Cedars-Sinai Medical Center)
- May 10 (9:00–10:30 am): The Westin New York at Times Square, New York City, NY
Joan Block (HBF), Dr. Albert Min (Beth Israel Medical Center), Dr. Qing Yeh (Internal Medicine, NY)
AIM for the B is a program sponsored by the Hepatitis B Foundation in partnership with Bristol-Myers Squibb and is designed to highlight chronic hepatitis B as an urgent health priority in the United States and to build better understanding of the disease.
|
 
|
